News &amp; Updates

Healthcare providers and other care partners need greater awareness and training on neurocognitive impairment, mental health, and comorbidities that afflict older people living with HIV (PLHIV), suggests a Singapore study.

Neurocognitive impairment plagues older PLHIV

CBT, mindfulness help improve sexual outcomes in prostate cancer

Mindfulness and cognitive behavioural therapy (CBT) appear beneficial for prostate cancer survivors and their partners who are dealing with sexual dysfunction, a study has shown.

CBT, mindfulness help improve sexual outcomes in prostate cancer

21 Mar 2023

New data support B/FTC/TAF use in HIV+ children

Data from a French study presented at CROI 2023 support the use of bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg (B/FTC/TAF) in the management of paediatric patients with HIV.

New data support B/FTC/TAF use in HIV+ children

Rifaximin helps improve symptoms of IBS with diarrhoea

Treatment with rifaximin appears to produce significant reductions in multiple, concurrent symptoms of irritable bowel syndrome (IBS) with diarrhoea, according to a study that uses a novel tri-symptom endpoint.

Rifaximin helps improve symptoms of IBS with diarrhoea

HCC risk in CHB patients persists 12 years after HBsAg loss

Patients with chronic hepatitis B (CHB) still have a non-negligible risk of hepatocellular carcinoma (HCC) 12 years after achieving hepatitis B surface antigen (HBsAg) seroclearance, especially if cirrhosis is present, a large territory-wide real-world study in Hong Kong has shown.

HCC risk in CHB patients persists 12 years after HBsAg loss

21 Mar 2023

Bempedoic acid cuts CV events in statin-intolerant patients

The use of bempedoic acid significantly reduced the risk of major adverse cardiovascular events (MACE) in patients with high cholesterol who are intolerant to statins in the phase III CLEAR* Outcomes trial presented at ACC.23/WCC.

Bempedoic acid cuts CV events in statin-intolerant patients

PCSK9 inhibition tied to decreased psoriasis risk

20 Mar 2023 by

Inhibition of the proprotein convertase subtilisin/kexin type 9 (PCSK9) pathway appears to be causally associated with a lower risk of psoriasis, regardless of the concentration levels of circulating low-density lipoprotein (LDL), according a two-sample Mendelian randomization study.

PCSK9 inhibition tied to decreased psoriasis risk

20 Mar 2023

Telbivudine use during pregnancy safe, effective in HBsAG-positive mothers

Use of telbivudine (LdT) during the second trimester of pregnancy helps prevent mother-to-child transmission of hepatitis B virus, reveals a study. In addition, treatment with LdT during pregnancy is safe in the long term for both mothers and infants.

Telbivudine use during pregnancy safe, effective in HBsAG-positive mothers

20 Mar 2023

ICD maintains shock function after MRI

20 Mar 2023 by

Non-magnetic resonance imaging (MRI)-conditional implantable cardioverter defibrillators (ICDs) are effective at treating detected tachyarrhythmias after MRI, with no serious adverse effects on device function seen, reports a study.

ICD maintains shock function after MRI

High iron level ups risk of noncommunicable disease in adolescents

A recent study in India has found a significant association between high serum ferritin (SF) and noncommunicable disease (NCD) in adolescents. Additionally, such interaction is dependent on wealth and coexisting prediabetes.

High iron level ups risk of noncommunicable disease in adolescents